✦
Cellular Health
Mitome Kit
Mitome is a cheek-swab test that measures the functional activity of the mitochondrial electron transport chain — the cellular machinery responsible for producing 90% of the body's energy. Created by nutritional biochemist Chris Masterjohn, PhD, it's positioned as the first DTC test to assess how well your mitochondria actually work, rather than sequencing genes that might affect them. The $699 kit delivers an 11–30 page personalized report with targeted supplement and food recommendations. It occupies novel territory in the testing landscape, though its scientific validation remains a work in progress.
MYM score
6.8
Biomarker depth 26%
7.5
⌄
Markers assessed5 (Citrate Synthase + Complexes I, II, II+III, IV)
What it capturesETC functional activity, not genetic variants
What it missesmtDNA copy number, ROS, CoQ10, direct ATP output
Report length11–30 pages, personalized
Five markers is a narrow panel by traditional DTC standards, but these five collectively characterize the respiratory chain in a way no blood panel does. Citrate synthase plus all four complexes gives you a functional fingerprint, not just a risk score. Points deducted because broader mitochondrial markers (CoQ10 status, oxidative stress, mtDNA density) would round out the picture.
Scientific validity 22%
5.5
⌄
Peer-reviewed validationNot independently published (as of May 2026)
Patent statusPending
Underlying scienceWell-established (ETC biochemistry, ME/CFS research)
Lab accreditationNot disclosed on site
Reference populationNot published
The broader science connecting mitochondrial dysfunction to chronic fatigue, cognitive decline, and metabolic disease is well-supported by the literature Mitome cites. The gap is in the test itself: measuring respiratory chain complexes from buccal (cheek) cells is a less-validated proxy for whole-body mitochondrial function compared to muscle biopsy gold standards. No peer-reviewed paper has been published validating Mitome's proprietary pattern classification system or its predictive accuracy. That's not unusual for an early-stage product, but it's a real limitation your readers deserve to know.
⚠ Flag for accuracy review: Lab accreditation not disclosed on mito.me — worth verifying directly before publishing.
Actionability 22%
8.0
⌄
Supplement protocolYes — specific to your mitochondrial type
Food recommendationsYes — personalized
Follow-up testingRecommended; re-test encouraged after protocol
Physician-shareableYes — report designed for functional medicine
Actionability is Mitome's strongest dimension. The report goes well beyond a biomarker printout — it delivers a tiered intervention plan with specific supplements, dosing rationale, and dietary modifications mapped to your individual ETC pattern. Multiple reviewers note that results were shareable with functional medicine doctors. One notable caveat: some protocols require purchasing a lactate meter for self-monitoring, which adds meaningful cost and complexity.
Value 17%
5.5
⌄
Kit price$699
SubscriptionNone required; re-testing optional
Hidden costsLactate meter (~$40–$80) + test strips if protocol requires
Annualized cost (yr 1)$699–$800+ depending on protocol
At $699 this is among the priciest single-test DTC products — more than Function Health's annual membership ($499) and significantly more than standard blood panels. The value case rests on the test's uniqueness: nothing else measures ETC function this way at this price point. For someone who has exhausted conventional diagnostics, that may be worth it. For general wellness curiosity, it's hard to justify before ruling out more accessible options.
Experience 13%
7.2
⌄
Sample collection5-minute buccal cheek swab at home
Turnaround3–5 weeks
Report format11–30 page PDF, personalized
Customer ratings4.9 / 5 · 2,000+ reviews
Collection is simple — a cheek swab beats a blood draw on every convenience metric. The 3–5 week turnaround is longer than most DTC competitors (Function Health and InsideTracker return results in days), which matters for people seeking answers to acute symptoms. Report quality scores high with reviewers; the depth of personalization stands out. Knock for turnaround time and the complexity of implementing some protocols without clinical support.
Mitochondrial health is an undercovered gap in DTC diagnostics.
Standard blood panels tell you about metabolic outputs — glucose, lipids, inflammatory markers — but not about the cellular machinery producing (or failing to produce) energy. For the estimated 17–24 million Americans with chronic fatigue-related conditions (including ME/CFS), conventional lab work routinely comes back normal while the underlying energy production problem goes undetected. Mitome is the first consumer product to address this gap directly, though the science behind its specific methodology is still maturing.
Strengths & limitations
Strengths
+Genuinely novel test — no comparable DTC product measures ETC function this way
+Non-invasive cheek swab; no lab visit or blood draw required
+Highly actionable report with specific, tiered supplement and food protocols
+Physician-shareable format; designed for functional medicine collaboration
+Strong customer reviews (4.9/5 across 2,000+) with detailed transformation accounts
Limitations
−No independent peer-reviewed validation of the proprietary pattern classification
−At $699, significantly more expensive than most DTC diagnostics
−3–5 week turnaround is slow compared to blood-based competitors
−Some protocols require purchasing a separate lactate meter to follow correctly
−Lab accreditation not disclosed publicly; hard to independently verify quality
How it compares
| Product | What it measures | Method | Turnaround | Cost |
|---|---|---|---|---|
| Mitome Kit This review | ETC complex activity, mitochondrial function | Cheek swab | 3–5 weeks | $699 |
MYM verdict
"Mitome earns serious attention for anyone who has hit a wall with conventional diagnostics — chronic fatigue, unexplained energy crashes, or post-illness recovery where standard bloodwork shows nothing. The science behind mitochondrial function testing is real and underutilized; the concern is that Mitome's proprietary classification system hasn't been independently validated yet. At $699, this is a considered purchase, not an impulse buy — but for the right person, there's nothing else like it on the market."